Multisystem Inflammatory Syndrome In Children
Half of kids with MIS-C experience neurological symptoms
Preliminary research suggested half of children at a London hospital who developed a multisystem inflammatory syndrome associated with COVID-19 experienced neurological symptoms, such as headache, encephalopathy and hallucinations.
Top in rheumatology: Autoimmune disease and COVID-19, ‘KawaCOVID’ in children
Researchers in Spain found that patients with inflammatory rheumatic disease had a greater risk for developing severe COVID-19 pneumonia than the general population.
Mucocutaneous symptoms common in pediatric COVID-19 hospitalizations
Pediatric patients who were hospitalized with COVID-19 often experienced mucocutaneous symptoms, according to a study.
COVID-19 positivity, myocarditis distinguish MIS-C from Kawasaki disease
COVID-19 positivity, older age at onset, and the presence of myocarditis are more common with multisystemic inflammatory syndrome in children than with Kawasaki disease, according to data published Pediatric Rheumatology.
MIS-C mystery persists even as rheumatologists' arsenal proves key to treatment
As physicians around the world scrambled throughout early 2020 to respond to the exploding COVID-19 pandemic, the one promising development appeared to be that children were at relatively low risk compared with adults.
Syndrome linked to COVID-19 disproportionately affects Black, Hispanic and Latino children
As of July 15, three dozen states and Washington, D.C., reported a total of 342 cases of a serious new inflammatory condition in children that has been associated with COVID-19.